RxDoctor Payments Data

Sami Khan, MD

Plastic and Reconstructive Surgery · Setauket, NYNPI 1043381791

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,000 of the $14,864 with a category attached, or 67.3%. TELA Bio, Inc. accounts for 88.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $10,036 and has fallen 87.5% since, to $1,257 in 2025.

$14,864in general payments, 2019–2025

Across 45 payments — averaging $330.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$13K
  • Integra Lifesciences Corporation$348
  • Avita Medical Americas, LLC$337
  • AbbVie$187
  • Sientra, Inc.$133
  • Organogenesis Inc.$127
  • plus $537 from 11 others

What the payments were for

  • Consulting fees$10,00067%
  • Speaking & faculty fees$2,50017%
  • Food & beverage$2,36416%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,864 in reported general payments places this provider in the 85th percentile of 219 plastic and reconstructive surgery providers in New York.

See all plastic and reconstructive surgery providers in New York

Medicare billing

Part B allowed, 2024
$257,571
Medicare patients
171
Services billed
2,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Setauket

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →